VOGLISUG-RAPID TAB - Repaglinide 1mg + Voglibose 0.3mg | Intralife Pharmaceuticals
DIASAGE
Premium

VOGLISUG-RAPID TAB

MRP: 1,800

Packaging: 10 x 10

Pack Type: tablet

Composition:

Repaglinide 1mg + Voglibose 0.3mg

Indication:

Helps control blood sugar levels by stimulating insulin release and slowing carbohydrate absorption, thereby reducing post-meal blood glucose spikes.

Description:

Repaglinide 1mg + Voglibose 0.3mg is an effective oral antidiabetic combination used to manage type 2 diabetes mellitus. This formulation combines two agents with complementary mechanisms:

  • Repaglinide (1mg): A meglitinide class drug that stimulates rapid insulin secretion from pancreatic beta cells, primarily targeting postprandial blood glucose spikes.

  • Voglibose (0.3mg): An alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestines, reducing post-meal blood sugar rises.

Together, these agents provide better control of postprandial glucose, helping maintain overall glycemic stability and reducing the risk of diabetes-related complications.

Tags:

Anti-diabetic Type 2 Diabetes Meglitinide Alpha-Glucosidase Inhibitor Blood Sugar Control Postprandial Glucose Oral Tablet
  • Controls postprandial blood sugar spikes effectively
  • Improves overall glycemic control in type 2 diabetes
  • Combines two complementary mechanisms for better results
  • Rapid onset of action due to Repaglinide
  • Delays carbohydrate absorption with Voglibose
  • Reduces risk of diabetes-related complications

Usage Information

Dosage

Take 1 tablet before each main meal (usually 2-3 times daily) Swallow whole with water, do not skip or delay meals Follow your doctor’s prescribed dosage strictly Monitor blood sugar regularly to avoid hypoglycemia

Side Effects

Hypoglycemia (low blood sugar) Gastrointestinal discomfort: flatulence, diarrhea, abdominal pain Dizziness or headache Allergic reactions (rare) Possible weight gain (due to Repaglinide)

Contraindications

Known allergy to Repaglinide or Voglibose Type 1 diabetes or diabetic ketoacidosis Severe liver or kidney impairment Pregnancy and breastfeeding without medical supervision Conditions causing hypoglycemia or digestive issues

Availability

Repaglinide Voglibose combination Repaglinide 1mg Voglibose 0.3mg tablets Postprandial blood sugar control Oral antidiabetic drugs for type 2 diabetes Alpha-glucosidase inhibitor with meglitinide Diabetes medicine for after meal sugar spikes Effective diabetes combination therapy Type 2 diabetes oral medication Blood glucose lowering tablets Diabetes treatment with repaglinide and voglibose

Repaglinide 1mg + Voglibose 0.3mg Combo Tablet for Diabetes Control | Intralife Pharmaceuticals | Intralife